BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31222720)

  • 21. Pharmacokinetic parameter estimations by minimum relative entropy method.
    Amisaki T; Eguchi S
    J Pharmacokinet Biopharm; 1995 Oct; 23(5):479-94. PubMed ID: 8656343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Model selection criterion for causal parameters in structural mean models based on a quasi-likelihood.
    Taguri M; Matsuyama Y; Ohashi Y
    Biometrics; 2014 Sep; 70(3):721-30. PubMed ID: 24621405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comparison of Regularized Maximum-Likelihood, Regularized 2-Stage Least Squares, and Maximum-Likelihood Estimation with Misspecified Models, Small Samples, and Weak Factor Structure.
    Finch WH; Miller JE
    Multivariate Behav Res; 2021; 56(4):608-626. PubMed ID: 32324059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence Re-weighted G-Estimation.
    Rich B; Moodie EE; A Stephens D
    Int J Biostat; 2016 May; 12(1):157-77. PubMed ID: 26234949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel approach to assess dynamic treatment regimes embedded in a SMART with an ordinal outcome.
    Ghosh P; Yan X; Chakraborty B
    Stat Med; 2023 Mar; 42(7):1096-1111. PubMed ID: 36726310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-stage least squares versus penalized quasi-likelihood for fitting hierarchical models in epidemiologic analyses.
    Greenland S
    Stat Med; 1997 Mar; 16(5):515-26. PubMed ID: 9089960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restricted sub-tree learning to estimate an optimal dynamic treatment regime using observational data.
    Speth K; Wang L
    Stat Med; 2021 Nov; 40(26):5796-5812. PubMed ID: 34340264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preserving data privacy when using multi-site data to estimate individualized treatment rules.
    Danieli C; Moodie EEM
    Stat Med; 2022 Apr; 41(9):1627-1643. PubMed ID: 35088914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable selection for binary spatial regression: Penalized quasi-likelihood approach.
    Feng W; Sarkar A; Lim CY; Maiti T
    Biometrics; 2016 Dec; 72(4):1164-1172. PubMed ID: 27061299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalization ability of fractional polynomial models.
    Lei Y; Ding L; Ding Y
    Neural Netw; 2014 Jan; 49():59-73. PubMed ID: 24140985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of variable selection approaches for dynamic treatment regimes.
    Biernot P; Moodie EE
    Int J Biostat; 2010; 6(1):Article 6. PubMed ID: 21969968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrating randomized and observational studies to estimate optimal dynamic treatment regimes.
    Batorsky A; Anstrom KJ; Zeng D
    Biometrics; 2024 Mar; 80(2):. PubMed ID: 38804219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ascertaining properties of weighting in the estimation of optimal treatment regimes under monotone missingness.
    Dong L; Laber E; Goldberg Y; Song R; Yang S
    Stat Med; 2020 Nov; 39(25):3503-3520. PubMed ID: 32729973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using decision lists to construct interpretable and parsimonious treatment regimes.
    Zhang Y; Laber EB; Tsiatis A; Davidian M
    Biometrics; 2015 Dec; 71(4):895-904. PubMed ID: 26193819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Empirical Bayes hierarchical models for regularizing maximum likelihood estimation in the matrix Gaussian Procrustes problem.
    Theobald DL; Wuttke DS
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18521-7. PubMed ID: 17130458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal individualized dosing strategies: A pharmacologic approach to developing dynamic treatment regimens for continuous-valued treatments.
    Rich B; Moodie EE; Stephens DA
    Biom J; 2016 May; 58(3):502-17. PubMed ID: 26537297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic Treatment Regimes Using Bayesian Additive Regression Trees for Censored Outcomes.
    Li X; Logan BR; Hossain SMF; Moodie EEM
    Lifetime Data Anal; 2024 Jan; 30(1):181-212. PubMed ID: 37659991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weighted least-squares approach for identification of a reduced-order adaptive neuronal model.
    Zhi L; Chen J; Molnar P; Behal A
    IEEE Trans Neural Netw Learn Syst; 2012 May; 23(5):834-40. PubMed ID: 24806132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of extended vs weighted least squares for parameter estimation in physiological modeling.
    Spilker ME; Vicini P
    J Biomed Inform; 2001 Oct; 34(5):348-64. PubMed ID: 12123152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive Bayesian inference and dynamic treatment regimes.
    Saarela O; Arjas E; Stephens DA; Moodie EE
    Biom J; 2015 Nov; 57(6):941-58. PubMed ID: 26259996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.